A national campaign to address the substance use treatment needs of adolescents.
Based on NIDA's publication: Principles of Adolescent Substance Use Disorder Treatment: A Research-Based Guide, this campaign will:
- familiarize treatment providers with research study outcomes
- provide strategies to incorporate those findings into practice
- address the implications for treating adolescents
Through the use of a social media campaign, quarterly updates and webinars conducted by experts in the field, users will learn about a variety of topics including:
- the developing brain
- behavioral therapies proven effective for adolescents
- treatment retention and cultural adaptions
- the importance of testing for sexually transmitted infections
Adolescent Substance Use Screening Tools for Use in Primary Care
Wednesday, November 9, 2016
1:00pm - 2:00pm Eastern (12pm Central / 11am Mountain /10am Pacific)
The National Institute on Drug Abuse (NIDA) provides two validated, web-based screening tools (BSTAD and S2BI) for use with adolescent patients at primary care settings, available at no cost from the NIDA website. Any substance use during adolescence is worrying, as this behavior is associated with a range of problemsâ€” including physical and mental health conditions, poor school performance, justice system involvement, and risk for developing a substance use disorder in adulthood. Detection of substance use can be followed by brief intervention in the office and/or referral to specialty care to prevent negative health and social consequences of continued use. For youth not reporting any substance use, screening can provide an opportunity for preventionâ€”through clinician reinforcement of healthy behaviors. Having tools that indicate clinically relevant risk categories of adolescent substance use allows clinicians to address substance use and refer youths for additional intervention when necessary.
Geetha Subramaniam, MD is the Deputy Director for NIDA's Center for Clinical Trials Network and a board certified Child and Adolescent and Addiction Psychiatrist.
Robert Schwartz, MD, Friends Research Institute Medical Director, is a psychiatrist and former Director of the Division of Alcohol and Drug Abuse in the Department of Psychiatry at the University of Maryland School of Medicine.
Sharon Levy, MD, MPH, is a board certified Developmental-Behavioral Pediatrician and an Assistant Professor of Pediatrics at Harvard Medical School. She is the Director of the Adolescent Substance Abuse Program (ASAP) in the Division of Developmental Medicine at Boston Children's Hospital
NIDA/SAMHSA-ATTC Adolescent Blending Team Members
- Phillip Orrick, Chair - South Southwest ATTC
- Jason Burrow-Sánchez, PhD - Central Rockies ATTC
- Leslie Cohen, BS - New England ATTC
- Marjean Searcy, SSW - Central Rockies ATTC
- Pat Stilen, LCSW - Mid-America ATTC